Ortiz, EE. Acute rheumatic fever. In: Anderson RH, Baker EJ,Macartney FJ, RigbyML, Shinebourne EA, Tynan M (eds). Paediatric Cardiology, vol. 2, 2nd edn. Churchill Livingstone, London, 2002: 1713–1731.
Ayoub, EM. Acute rheumatic fever. In: Allen HD, Shaddy RE, Feltes TF, Driscoll DJ (eds). Moss and Adams’ Heart Disease in Infants, Children and Adolescents, 7th edn. Lippincott Williams and Wilkins, Philadelphia, 2008: 1256–1280.
Cilliers, AM. Rheumatic fever and its management. BMJ
2006; 333: 1153–1156.
Dajani, AS, Ayoub, E, Bierman, FZ, et al.
Guidelines for the diagnosis of acute rheumatic fever. Jones criteria 1992 update. Special Writing Group of the Committee on Rheumatic Fever, Endocarditis, and Kawasaki Disease of the Council on Cardiovascular Disease in the Young of the American Heart Association. JAMA
1992; 268: 2069–2073.
Ferreri, P. Proceedings of the Jones criteria workshop. Circulation
2002; 106: 2521–2523.
Matsuwaza, Y. Adiponectin: identification, physiology and clinical relevance in metabolic and vascular disease. Atheroscler Suppl
2005; 6: 7–14.
Guzik, TJ, Mangalat, D, Korbut, R. Adipocytokines-novel link between inflammation and vascular function?
J Physiol Pharmacol
2006; 57: 505–528.
Tilg, H, Moschen, AR. Adipocytokines: mediators linking adipose tissue, inflammation and immunity. Nat Rev Immnol
2006; 6: 772–783.
Ryo, M, Nakamura, T, Kihara, S. Adiponectin as a biomarker of the metabolic syndrome. Circ J
2004; 68: 975–981.
Fallo, F, Scarda, A, Sonino, N, et al.
Effect of glucocorticoids on adiponectin: a study in healthy subjects and in Cushing’s syndrome. Eur J Endocrinol
Takeshita, S, Takabayashi, H, Yoshida, N. Circulating adiponectin levels in Kawasaki Disease. Clin Observ
Senolt, L, Pavelka, K, Housa, D, Haluzík, M. Increased adiponectin is negatively linked to the local inflammatory process in patients with rheumatoid arthritis. Cytokine
Elenkov, IJ, Chrousos, GP. Stress hormones, proinflammatory and antiinflammatory cytokines, and autoimmunity. Ann N Y Acad Sci
2002; 966: 290–303.
Zedan, MM, el-Shennawy, FA, Abou-Bakr, HM, al-Basousy, AM. Interleukin-2 in relation to T cell subpopulations in Rheumatic heart disease. Arch Dis Child
1992; 67: 1373–1375.
Miller, LC, Gray, ED, Mansour, M, et al. Cytokines and immunoglobulin in rheumatic heart disease: production by blood and tonsillar mononuclear cells. J Rheumatol
1989; 16: 1436–1442.
Morris, K, Mohan, C, Wahi, PL, Anand, IS, Ganguly, NK. Enhancement of IL-1, IL-2 production and IL-2 receptor generation in patients with acute rheumatic fever and active rheumatic heart disease; a prospective study. Clin Exp Immunol
1993; 91: 429–436.
Narin, N, Kütükçüler, N, Özyürek, R, Bakiler, AR, Parlar, A, Arcasoy, M. Lymphocyte subsets and plasma IL-1 alpha, IL-2, and TNF-α concentrations in acute rheumatic fever and chronic rheumatic heart disease. Clin Immunol Immunopathol
1995; 77: 172–176.
Yegin, O, Coskun, M, Ertug, H. Cytokines in acute rheumatic fever. Eur J Pediatr
1997; 156: 25–29.
Kütükçüler, N, Narin, N. Plasma interleukin-7 (IL-7) and IL-8 concentrations in acute rheumatic fever and chronic rheumatic heart disease. Scand J Rheumatol
1995; 24: 383–385.
Lawlor, DA, Smith, GD, Ebrahim, S. Plasma adiponectin levels are associated with insulin resistance, but do not predict future risk of coronary heart disease in women. J Clin Endocrinol Metab
2005; 90: 5677–5683.
Panamonta, M, Settasatian, N, Kaplan, EL, Chaikitpinyo, A. Serum cholesterol levels in patients with acute rheumatic fever. American J of Diseases of Children
1993; 147: 732–736.
Ouchi, N, Walsh, K. Adiponectin as an anti-inflammatory factor. Clinica Chimica Acta
2007; 380: 24–30.
Ogawa, Y, Kikuchi, T, Nagasaki, K, Hiura, M, Tanaka, Y, Uchiyama, M. Usefulness of serum adiponectin level as a diagnostic marker of metabolic syndrome in obese Japanese children. Hypertens Res
2005; 28: 51–57.
Ko, GT, So, WY, Tong, P, et al. Hypoadiponectinaemia enhances waist circumference as a predictor of glucose intolerance and clustering of risk factors in Chinese men. Diabetes Metab
2010; 36: 192–197.
Vitoratos, N, Deliveliotou, A, Vlahos, NF, et al. Serum adiponectin during pregnancy and postpartum in women with gestational diabetes and normal controls. Gynecol Endocrinol
2008; 24: 614–619.
Tsuchihashi, H, Yamamoto, H, Maeda, K, et al. Circulating concentrations of adiponectin, an endogenous lipopolysaccharide neutralizing protein, decrease in rats with polymicrobial sepsis. J Surg Res
2006; 134: 348–353.
Fantuzzi, G. Adiponectin and inflammation: consensus and controversy. J Allergy Clin Immunol
2008; 121: 326–330.
Schaffler, A, Ehling, A, Neumann, E, Herfarth, H, Tarner, I, Scholmerich, J. Adipocytokines in synovial fluid. JAMA
2003; 290: 09–10.
Chen, TH, Chen, L, Hsieh, MS, Chang, CP, Chou, DT, Tsai, SH. Evidence for a protective role for adiponectin in osteoarthritis. Biochim Biophys Acta
2006; 1762: 711–718.
Fayad, R, Pini, M, Sennello, JA, et al. Adiponectin deficiency protects mice from chemically induced colonic inflammation. Gastroenterology
2007; 132: 601–614.
Shore, SA, Terry, RD, Flynt, L, Xu, A, Hug, C. Adiponectin attenuates allergen-induced airway inflammation and hyperresponsiveness in mice. J Allergy Clin Immunol
2006; 118: 389–395.
Rothenbacher, D, Weyermann, M, Fantuzzi, G, Brenner, H. Adipokines in cord blood and risk of wheezing disorders within the first two years of life. Clin Exp Allergy
2007; 37: 1143–1149.
Lee, SW, Kim, JH, Park, MC, Park, YB, Lee, SK. Adiponectin mitigates the severity of arthritis in mice with collagen-induced arthritis. Scand J Rheumatol
2008; 37: 260–268.
Kitahara, K, Kusunoki, N, Kakiuchi, T, Suguro, T, Kawai, S. Adiponectin stimulates IL-8 production by rheumatoid synovial fibroblasts. Biochem Biophys Res Commun
2009; 378: 218–223.